About 3-bromo-5-chloro-N-[[(3S)-oxolan-3-yl]methyl]pyrazolo[1,5-a]pyrimidin-7-amine
3-bromo-5-chloro-N-[[(3S)-oxolan-3-yl]methyl]pyrazolo[1,5-a]pyrimidin-7-amine (PubChem CID 118452759) has the molecular formula C11H12BrClN4O
and a molecular weight of 331.60 g/mol. Its IUPAC name is 3-bromo-5-chloro-N-[[(3S)-oxolan-3-yl]methyl]pyrazolo[1,5-a]pyrimidin-7-amine.
Analyze 3-bromo-5-chloro-N-[[(3S)-oxolan-3-yl]methyl]pyrazolo[1,5-a]pyrimidin-7-amine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 3-bromo-5-chloro-N-[[(3S)-oxolan-3-yl]methyl]pyrazolo[1,5-a]pyrimidin-7-amine?
The IUPAC name of 3-bromo-5-chloro-N-[[(3S)-oxolan-3-yl]methyl]pyrazolo[1,5-a]pyrimidin-7-amine (CID 118452759) is 3-bromo-5-chloro-N-[[(3S)-oxolan-3-yl]methyl]pyrazolo[1,5-a]pyrimidin-7-amine.
What is the SMILES notation for 3-bromo-5-chloro-N-[[(3S)-oxolan-3-yl]methyl]pyrazolo[1,5-a]pyrimidin-7-amine?
The canonical SMILES for 3-bromo-5-chloro-N-[[(3S)-oxolan-3-yl]methyl]pyrazolo[1,5-a]pyrimidin-7-amine is Clc1cc(NC[C@@H]2CCOC2)n2ncc(Br)c2n1.
What is the InChIKey of 3-bromo-5-chloro-N-[[(3S)-oxolan-3-yl]methyl]pyrazolo[1,5-a]pyrimidin-7-amine?
The InChIKey is MLHZAYNXVPEKTD-ZETCQYMHSA-N. The full InChI is InChI=1S/C11H12BrClN4O/c12-8-5-15-17-10(3-9(13)16-11(8)17)14-4-7-1-2-18-6-7/h3,5,7,14H,1-2,4,6H2/t7-/m0/s1.
What are the key properties of 3-bromo-5-chloro-N-[[(3S)-oxolan-3-yl]methyl]pyrazolo[1,5-a]pyrimidin-7-amine?
3-bromo-5-chloro-N-[[(3S)-oxolan-3-yl]methyl]pyrazolo[1,5-a]pyrimidin-7-amine has a molecular weight of 331.60 g/mol, XLogP of 2.59, 3 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 3-bromo-5-chloro-N-[[(3S)-oxolan-3-yl]methyl]pyrazolo[1,5-a]pyrimidin-7-amine is sourced from PubChem (CID 118452759), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).